Lakewood-Amedex Biotherapeutics Inc. (LABT) Free cash flow
Lakewood-Amedex Biotherapeutics Inc. (LABT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.7MFY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$5.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LABT financial trends
LABT RevenueLABT Net incomeLABT Net marginLABT Gross profitLABT Gross marginLABT Operating incomeLABT Operating marginLABT Operating cash flowLABT Capital expendituresLABT Return on equityLABT Stock buybacksLABT Dividends paidLABT Total assetsLABT Total liabilitiesLABT Shareholders’ equityLABT overview →